Ingrid Oakley-Girvan

All Publications

Zeliadt SB, Ramsey SD, Van Den Eeden SK, Hamilton AS, Oakley-Girvan I, Penson DF, Fairweather ME, Arora NK, Potosky AL. Patient Recruitment Methods to Evaluate Treatment Decision Making for Localized Prostate Cancer. Am J Clin Oncol [epub ahead of print]. (PMID: 20010079)
.
Ramsey SD, Zeliadt SB, Arora NK, Potosky AL, Blough DK, Hamilton AS, Van Den Eeden SK, Oakley-Girvan I, Penson DF. Access to Information Sources and Treatment Considerations Among Men with Local Stage Prostate Cancer. Urology 2009;74:509-16. (PMID: 19586564).

Zeliadt SB, Ramsey SD, Potosky AL, Arora NK, Blough DK, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Penson DF. Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients. The Patient: Patient-Centered Outcomes Research 2008;1(3):189-200. (needs PMID).

Beckjord EB, Arora NK, Mclaughlin W, Oakley-Girvan I, Hamilton AS, Hesse BW. Health-related information needs in a large and diverse sample of adult cancer survivors: implications for cancer care. J. Cancer Surviv 2008;2(3):179-89. (PMID: 18792791).

Beckjord EB, Arora NK, Mclaughlin W, Oakley-Girvan I, Hamilton AS, Hesse BW. Population-Based Assessment of Long-Term Survivors’ Information Needs: Implications for Cancer Care. Accepted for publication Journal of Cancer Survivorship: Research and Practice 2008 (needs PMID).

Borugian MJ, …, Oakley-Girvan I, … Gallagher RP. Prostate Cancer Risk in Relation to Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3: A Prospective Multiethnic Study.CEBP 2008 Jan;17(1):252-4. (PMID: 18199733).

Borugian, MJ, ….Oakley-Girvan I, …. Gallagher, RP. Pre-diagnostic C-peptide and risk of prostate cancer. CEBP 2007;16(10):2164-5. (PMID: 17932367).

SJ Ramus, … Oakley-Girvan I, … Gayther SA. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Human Mutation 2007;28(12):1207-15. (PMID: 17688236).

Camp NJ, Cannon-Albright AL, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailery-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WED, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Coonery KA, Tammela TL, Schleutker J, Paiss T, Maier C, Gronberg H, Wiklund F, Emanuelsson M, Isaacs WB.  Compelling Evidence for a Prostate Cancer Gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics.  Hum Mol Genet 2007;16(11):1271-8. (PMID: 17478474). 

Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Marchand LL, Kolonel LN, Frasco M, Wong D, Pooler LC, Ardlie K, Oakley-Girvan I, Whittemore AS, Cooney KA, John EM, Ingles SA, Altshuler D, Henderson BE and Reich D: Multiple regions within 8q24 independently affect risk for prostate cancer.  Nat Genet 2007;39(5):638-44. (PMID:17401364).

Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I, Assessment of Quality of Care from Cancer Survivors’ Perspective: A Population-based Study. Abstract Accepted Academy of Health January 2007.

Bloom JR, Stewart SL, Oakley-Girvan I, Banks PJ, Chang S.  Family history, perceived risk and prostate cancer screening among African-American men.  CEBP 2006;15(11):2167-73. (PMID: 17119042).

Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Montague C, Ardlie K, John EM, Oakley-Girvan I, Whittemore AS, Cooney KA, Ingles SA, Altshuler D, Henderson BE, Reich D.  Admixture mapping identifies 8q24 as an early onset prostate cancer locus in African American men. Proc Natl Acad Sci USA 2006;103(38):14068-14073.  (PMID: 16945910).

Xu J, Dimitrov L, Chang BL, Meyers DA, Eeles R, Easton D, Foulkes W, Simard J, Badzioch M, Hopper J, Giles G, Mahle L, Moller P, Bishop T, Evans C, Edwards  S, Meitz J, Bullock S, Hope Q, Hsieh CL, Halpern J, Balise  RR, Oakley-Girvan I, Whittemore AS, Wiley KE, Isaacs SD, Ewing CM, Gielzak M, Walsh PC, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Kolb S, Jarvik GP, Janer M, Hood L, Ostrander EA, Stanford  J, Lange EM, Beebe-Dimmer JL, Mohai C, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLJ, Bailey-Wilson J, Schleutker  J, Maier C, Herkommer K, Hoegel  J, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Grönberg H, Seminara D.  A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J of Hum Genet 2005;77(2):219-229.  (PMID: 15988677).

Schaid DJ, Chang BL, and The International Consortium for Prostate Cancer Genetics (BC/CA/HI/SF Group:  Balise RR, Gallagher RP, Halpern J, Hsieh C, Kolonel LN, Oakley-Girvan I, West DW, Whittemore AS and Wu A).  Description of the International Consortium for Prostate Cancer Genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13. The Prostate 2005;63:276-290.  (PMID: 16932970).

Whittemore AS, Balise RR, Pharoah PDP, DiCioccio RA , Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BAJ, Buys S, Senie R, Andrulis I, John E, Hopper JL, Piver MS. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. British Journal of Cancer 2004;91:1911-15.  (PMID: 15545966).

Oakley-Girvan I, Feldman D, Eccleshall TR, Gallagher RP, Wu AH, Kolonel LN, Halpern J, Balise RR, West DW, Paffenbarger RS Jr., Whittemore AS. Prostate cancer risk in relation to germline polymorphisms of the Vitamin D receptor. CEBP  2004;13:1325-1330.  (PMID: 15298953).

Werness BA, Ramus SJ, DiCioccio RA , Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Tsukada Y, Harrington P, Gayther SA, Ponder B, Piver MS.  Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Int J Gynecol Pathol 2004;23(1):29-34. (PMID: 14668547). 

Oakley-Girvan I, Kolonel LN, Gallagher RP, Wu AH, Felberg A, West DW, Paffenbarger RS Jr., Whittemore AS. Stage at diagnosis and survival in a multi-ethnic cohort of prostate cancer patients. Am J Pub Health 2003;93(10):1753-1759. (PMID: 14534233).

Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS. Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States. Cancer Causes Control 2002;13:471-482. (PMID: 12146852).

Hsieh CL, Oakley-Girvan I, Balise RR, Halpern J, Gallagher RP, Wu AH, Kolonel LN, O'Brien LE, Lin IG, Van Den Berg DJ, Teh CZ, West DW, Whittemore AS.  A genome screen of families with multiple cases of prostate cancer: evidence for genetic heterogeneity. Am J Hum Genet 2001;69:148-158. (PMID: 11404817).

Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Tsukada Y, Ponder BAJ, Piver MS: Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations. Hum Pathol 2000;31(11):1420-1424.

Werness BA, Parvatiyar P, Ramus S, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder B, Piver M.  Ovarian carcinoma in-situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.  JNCI 2000;92:1088-1091. (PMID: 10880552).

Werness BA, Ramus S, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Tsukada Y, Ponder B, Piver MS. Primary ovarian germ dysgerminoma in a patient with a germline BRCA1 mutation.  Intl J Gynecol Pathol 2000;19:390-394. (PMID: 11109172). 

Werness BA, Parvatiyar P, Ramus S, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder B, Piver M. Ovarian carcinoma in-situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.  J Natl Cancer Inst 2000;92:1088-1091. 

McGuire V, Whittemore AS, Norris R, Oakley-Girvan I. Survival in epithelial ovarian cancer patients with prior breast cancer.  Am J Epidemiol 2000;152:528-532. (PMID: 10997542).

Bosland MC, Oakley-Girvan I, Whittemore AS. Dietary fat, calories, and prostate cancer risk (editorial).  J Natl Cancer Inst 91: 489-490, 1999. 

Whittemore AS, Lin IG, Oakley-Girvan I, Gallagher RP, Halpern J, Kolonel LN, Wu AH, Hsieh C-L. No evidence of linkage for chromosome 1q42.2-43 in prostate cancer (letter). AJHG 1999;65:254-256. (PMID: 10364541). 

Hsieh C-L, Oakley-Girvan I, Gallagher RP, Wu AH, Kolonel LN, Teh C-Z, Halpern J, West DW, Paffenbarger RS Jr., Whittemore AS: Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study (letter). J Natl Cancer Inst 1997;89:1893-1894. (PMID: 9414179).

Jishi MF, Itnyre JH, Oakley-Girvan IA, Piver MS, Whittemore AS. Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer Registry.  Cancer 1995;76:1416-1421. (8620417).

Mistretta CM, Oakley IA. Quantitative anatomical study of taste buds in fungiform papillae of young fischer rats.  J Gerontol 1986;41:315-318. 


Back to Ingrid Oakley-Girvan's profile